Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science |
Stages | Expansion, Later Stage |
Investing | United States • Canada |
Assets Under Management | $180,000,000 |
Miraki Innovation is a venture capital firm that specializes in the healthcare sector, particularly focusing on medical technology, life science, and biotechnology. With their headquarters located at 888 Boylston Street, Suite 500, Boston, Massachusetts, Miraki Innovation operates primarily in the field of equity investments. Their strategy encompasses supporting companies that are in the expansion and later stages of development, where Miraki Innovation can provide substantial value through their expertise and financial backing. As a Venture Capital Fund, they manage assets totaling $180 million, which are allocated across various innovative firms in the BioTech, HealthTech (& Fitness), and Medical Devices (& Hospital Services) industries. By identifying and nurturing high-potential businesses within these industries, Miraki Innovation aims to foster groundbreaking advancements that can address some of the most pressing medical and health challenges. Their investment thesis revolves around engaging with transformative companies that demonstrate strong potential for growth and a clear roadmap for success. Their approach is to leverage their capital, network, and industry knowledge to help portfolio companies scale their operations and make a significant impact in the healthcare landscape. Miraki Innovation's dedication to molding the future of healthcare through strategic investments is at the core of their mission, marking them as an influential player in the venture capital healthcare niche.